Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | ISOX | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.09 | 0.7 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |